Maryland Woman Inadvertently Buys Counterfeit Supplements on Amazon.com

August 29, 2019

Annapolis, Maryland resident Michele Marshall maintains she received counterfeit supplements from Amazon.com. Ms. Marshall purchased a probiotic supplement called Align from Amazon.com in April 2019. The actual seller was a third-party site offering the supplements for sale as a ‘Prime’ purchase, meaning the product is guaranteed to arrive in 2 days and is promoted among the first offering seen by Amazon customers when they conduct a product search.

Read More

Drug Importation By the Numbers

August 28, 2019

When broken down to the nuts and bolts of implementation and operational execution, current drug importation plans fall apart. Drug Importation is neither a safe nor cost-effective solution.  The numbers do not lie.

Read More

Cancer Center Pharmacist in Iowa Worries Drug Importation Will Harm His Patients

August 27, 2019

This editorial by Dana McDougall was published in The Waterloo Cedar Falls Courier on August 26, 2019. Mr. McDougall, Pharm.D., BCPS, is a pharmacist with the Covenant Cancer Treatment Center in Waterloo, Iowa.

Read More

PSM Statement on Florida’s Submission of Irresponsible Drug Importation Concept Document

August 25, 2019

WASHINGTON (August 26, 2019) – Shabbir Imber Safdar, Executive Director of The Partnership for Safe Medicines, released the following statement in response to Florida’s submission of a drug importation concept to the U.S. Department of Health and Human Services (HHS): “Florida’s Canadian Prescription Drug Importation Concept Paper [PDF] recently submitted to HHS demonstrates that Florida…

Read More

DEA Issues Warning After Counterfeit Adderall Made with Methamphetamine Seized

August 22, 2019

The Drug Enforcement Administration (DEA) is warning the public after the seizure of counterfeit pills designed to look like Adderall, a medication used to treat Attention-deficit/Hyperactivity Disorder. The pills in question were tested and were found to be composed of illicit methamphetamine.

Read More

UK House of Commons: No Deal Brexit Exposes U.K. to Both Counterfeit Medication and Medication Shortages

August 21, 2019

In a report published by the House of Commons, experts in the field of prescription medication described a dire situation for medicine safety in the United Kingdom (UK) if a “no-deal” departure from the European Union (EU) happens. The report noted, “Witnesses told us that, without provisions with the EU to continue to exchange data, the UK would be shut out of critical EU data exchanges on pharmacovigilance, falsified medicines and clinical trials.”

Read More

Economist Demonstrates That U.S. Drug Importation Would Endanger Canada’s Prescription Medication Supply

August 14, 2019

This editorial by Fergus Hodgson was published in the Epoch Times on August 14, 2019. Mr. Hodgson is an independent economic consultant, and Executive Editor of the Antigua Report.

Read More

Senator McSally Meets with Experts on the Counterfeit Drug Trade

August 14, 2019

The Arizona Republic has reported that Executive Director Shabbir Safdar, along with Maricopa County Sheriff Paul Penzone, Pinal County Sheriff Mark Lamb, U.S. Drug Enforcement Administration special agent in charge Doug Coleman, and Phoenix-area pharmacist Randle House and met with U.S. Senator Martha McSally in Arizona on August 8th to seek her assistance and support for efforts to protect the U.S. prescription drug supply from counterfeit medication

Read More

Canadians Concerned About US Prescription Drug Importation Proposals

August 8, 2019

John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.

Read More

Economist Warns that Federal Drug Importation is Folly

August 7, 2019

This editorial by Wayne Winegarden, Ph.D. appeared in Forbes on August 7, 2019. Dr. Winegarden is the Managing Editor for EconoSTATS and a senior Fellow in Business and Economics at the Pacific Research Institute.

Read More